Parkinson's disease: recent development in therapies for advanced disease with a focus on deep brain stimulation (DBS) and duodenal levodopa infusion

被引:11
|
作者
Sydow, Olof [1 ]
机构
[1] Karolinska Univ Hosp, Dept Neurol, S-17176 Stockholm, Sweden
关键词
CDS; DBS; deep brain stimulation; duodenal infusion; Duodopa (R); L-dopa; fluctuations; levodopa; 'on-off'; Parkinson's disease;
D O I
10.1111/j.1742-4658.2008.06295.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Effective medical treatment for Parkinson's disease has been available for almost 40 years. After several years of treatment with L-dihydroxyphenylalanine (L-dopa, levodopa), however, fluctuations often occur. The patient may then experience random variations of the motor symptoms during the day. The medication becomes increasingly complicated. New therapeutic methods, deep brain stimulation and duodenal infusion of L-dopa, have proven to be very effective in stabilizing the fluctuations. A clinical update of Parkinson's disease is presented together with a short review of these two methods.
引用
收藏
页码:1370 / 1376
页数:7
相关论文
共 50 条
  • [1] Comparison of bilateral subthalamic deep brain stimulation (STN-DBS) and duodenal levodopa infusion (DLI) in advanced Parkinson's disease (PD) patients
    Zibetti, M.
    Cinquepalmi, A.
    Angrisano, S.
    Azzaro, C.
    Rizzi, L.
    Lanotte, H.
    Lopiano, L.
    MOVEMENT DISORDERS, 2010, 25 (07) : S459 - S459
  • [2] Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
    Clarke, Carl E.
    Worth, Paul
    Grosset, Donald
    Stewart, David
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (10) : 728 - 741
  • [3] Duodenal levodopa infusion in patients with advanced Parkinson's disease
    Caceres-Redondo, M. T.
    Carrillo, F.
    Lama, M. J.
    Carballo, M.
    Mir, P.
    MOVEMENT DISORDERS, 2012, 27 : S39 - S39
  • [4] Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson's Disease
    Antonini, Angelo
    JOURNAL OF MOVEMENT DISORDERS, 2009, 2 (01) : 4 - 9
  • [5] Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease'
    Regidor, Ignacio
    Benita, Vicente
    del Alamo de Pedro, Marta
    Ley, Luis
    Martinez Castrillo, Juan Carlos
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (03) : 103 - 107
  • [6] The INVEST study: A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson's disease
    van Poppelen, D.
    de Bie, R.
    Dijk, J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 402 - 402
  • [7] A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson's disease: The INVEST study
    van Poppelen, D.
    de Bie, R. M. A.
    Dijk, J. M.
    MOVEMENT DISORDERS, 2016, 31 : S611 - S612
  • [8] Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
    Calandrella, Daniela
    Romito, Luigi M.
    Elia, Antonio E.
    Del Sorbo, Francesca
    Bagella, Caterina F.
    Falsitta, Massimo
    Albanese, Alberto
    NEUROLOGY, 2015, 84 (16) : 1669 - 1672
  • [9] DUODENAL LEVODOPA INFUSION FOR ADVANCED PARKINSON'S DISEASE: REPORT OF SIX PATIENTS
    Valero, C.
    Burguera, J. A.
    Torres, I.
    Yaya, R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [10] Duodenal levodopa infusion for the treatment of Parkinson's disease
    Samanta, Johan
    Hauser, Robert A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (05) : 657 - 664